ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 123 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 2.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $2,217,000 | +66.4% | 117,542 | +3.9% | 0.00% | +100.0% |
Q2 2019 | $1,332,000 | -13.7% | 113,142 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $1,544,000 | +37.4% | 113,142 | +3.2% | 0.00% | +100.0% |
Q4 2018 | $1,124,000 | -38.4% | 109,642 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $1,826,000 | +5.4% | 109,642 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,732,000 | +24.4% | 109,642 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $1,392,000 | +10.9% | 109,642 | 0.0% | 0.00% | +100.0% |
Q4 2017 | $1,255,000 | +5.3% | 109,642 | +12.6% | 0.00% | 0.0% |
Q3 2017 | $1,192,000 | +56.8% | 97,342 | +46.7% | 0.00% | 0.0% |
Q2 2017 | $760,000 | -44.9% | 66,342 | 0.0% | 0.00% | -50.0% |
Q1 2017 | $1,380,000 | +2.6% | 66,342 | +2.6% | 0.00% | 0.0% |
Q4 2016 | $1,345,000 | -36.5% | 64,642 | 0.0% | 0.00% | -33.3% |
Q3 2016 | $2,118,000 | +33.5% | 64,642 | +1.7% | 0.00% | 0.0% |
Q2 2016 | $1,587,000 | +82.8% | 63,542 | +72.7% | 0.00% | +50.0% |
Q1 2016 | $868,000 | -6.8% | 36,800 | +30.5% | 0.00% | 0.0% |
Q4 2015 | $931,000 | +0.8% | 28,200 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $924,000 | -28.2% | 28,200 | +16.0% | 0.00% | -33.3% |
Q2 2015 | $1,287,000 | – | 24,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |